Bone, inflammation, and inflammatory bowel disease

Curr Osteoporos Rep. 2011 Dec;9(4):251-7. doi: 10.1007/s11914-011-0077-9.


Osteoporosis is a leading cause of morbidity in patients with inflammatory bowel disease (IBD). Bone loss is an early systemic process and occurs even before clinical disease manifests. Bone disease is attributed to vitamin D deficiency, steroid use, and/or systemic inflammation. In this review, we discuss the molecular pathways of bone loss mediated by inflammatory cytokines and other mediators. Further research will hopefully clarify the mechanisms of inflammation-induced bone loss in IBD and guide effective treatment modalities.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cell Communication / physiology
  • Humans
  • Inflammation / physiopathology*
  • Inflammatory Bowel Diseases / physiopathology*
  • Osteoblasts / cytology
  • Osteoblasts / physiology
  • Osteoclasts / cytology
  • Osteoclasts / physiology
  • Osteoporosis / physiopathology*
  • Signal Transduction / physiology
  • Vitamin D Deficiency / physiopathology